Clinical Trial Update: A Safety and Pharmacokinetics Study of IDP-118 Lotion in Pediatric Participants With Plaque Psoriasis [Phase 4]

View source ↗

Summary

Phase 4 safety and pharmacokinetics study evaluating IDP-118 Lotion in pediatric participants with plaque psoriasis has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• IDP-118 Lotion (IDP-118 lotion)

Snippet

Sponsor: Bausch Health Americas, Inc. | Conditions: Psoriasis | Phase 4 | Status: COMPLETED